JP2010540530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540530A5 JP2010540530A5 JP2010526961A JP2010526961A JP2010540530A5 JP 2010540530 A5 JP2010540530 A5 JP 2010540530A5 JP 2010526961 A JP2010526961 A JP 2010526961A JP 2010526961 A JP2010526961 A JP 2010526961A JP 2010540530 A5 JP2010540530 A5 JP 2010540530A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- use according
- placental perfusate
- isolated
- placental
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100016492 CD34 Human genes 0.000 claims 37
- 108060001251 CD34 Proteins 0.000 claims 37
- 230000003169 placental Effects 0.000 claims 30
- 210000004700 Fetal Blood Anatomy 0.000 claims 9
- 102100005499 PTPRC Human genes 0.000 claims 8
- 101700059076 PTPRC Proteins 0.000 claims 8
- 102100002212 CXCR4 Human genes 0.000 claims 6
- 101710003734 CXCR4 Proteins 0.000 claims 6
- 102100013180 KDR Human genes 0.000 claims 6
- 102100018954 PECAM1 Human genes 0.000 claims 6
- 101710027269 PECAM1 Proteins 0.000 claims 6
- 108091007928 VEGF receptors Proteins 0.000 claims 6
- 210000002826 Placenta Anatomy 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 210000004204 Blood Vessels Anatomy 0.000 claims 4
- 210000004369 Blood Anatomy 0.000 claims 3
- 210000001185 Bone Marrow Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 239000011159 matrix material Substances 0.000 claims 3
- 239000011886 peripheral blood Substances 0.000 claims 3
- 102000005741 Metalloproteases Human genes 0.000 claims 2
- 108010006035 Metalloproteases Proteins 0.000 claims 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N Tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 2
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 claims 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000005755 formation reaction Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 208000005846 Cardiomyopathy Diseases 0.000 claims 1
- 206010061255 Ischaemia Diseases 0.000 claims 1
- 208000010125 Myocardial Infarction Diseases 0.000 claims 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 claims 1
- 206010062585 Peripheral arterial occlusive disease Diseases 0.000 claims 1
- 206010034636 Peripheral vascular disease Diseases 0.000 claims 1
- 208000002815 Pulmonary Hypertension Diseases 0.000 claims 1
- 208000004124 Rheumatic Heart Disease Diseases 0.000 claims 1
- 230000001154 acute Effects 0.000 claims 1
- 230000036765 blood level Effects 0.000 claims 1
- 201000008031 cardiomyopathy Diseases 0.000 claims 1
- 230000000271 cardiovascular Effects 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 201000006233 congestive heart failure Diseases 0.000 claims 1
- 201000010238 heart disease Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 201000011528 vascular disease Diseases 0.000 claims 1
Claims (37)
- 胎盤灌流液細胞の集団から血管を形成する方法であって、前記細胞の集団を血管の形成を促進する条件にインビトロで接触させるステップを含む方法。
- 前記胎盤灌流液細胞の集団が胎盤灌流液由来の全有核細胞である、請求項1に記載の方法。
- 前記接触が、前記細胞をVEGF(50〜200ng/mL)、TGF−β(1〜5ng/mL)、FGF(10〜50ng/mL)及び1つ又はそれ以上のマトリクスメタロプロテアーゼ(各々1〜3Unit/mL)に接触させるステップを含む、請求項1に記載の方法。
- 前記胎盤灌流液細胞の集団が、単一の胎盤の灌流から単離される胎盤灌流液細胞を含む、請求項1に記載の方法。
- 前記胎盤灌流液細胞がCD34+細胞である、請求項4に記載の方法。
- 前記CD34+細胞がCD34+CD45−細胞である、請求項5に記載の方法。
- 前記CD34+細胞又はCD34+CD45−細胞が、CD31、CXCR4又はVEGFRの少なくとも1つを、臍帯血由来の同等数のCD34+細胞より高いレベルで発現する、請求項4又は5に記載の方法。
- 前記胎盤灌流液細胞の集団が、前記灌流液から単離されない単離CD34+細胞を含む、請求項1に記載の方法。
- 前記CD34+細胞が胎盤から単離される、請求項8に記載の方法。
- 前記CD34+細胞が、臍帯血、胎盤血、末梢血又は骨髄から単離される、請求項8に記載の方法。
- 前記CD34+細胞が、CD31、CXCR4又はVEGFRを臍帯血由来の同等数のCD34+細胞より高いレベルで発現する、請求項8に記載の方法。
- 前記CD34+細胞がCD34+,CD45−細胞である、請求項8に記載の方法。
- 血管を形成するための医薬の製造における胎盤灌流液細胞の集団の使用であって、前記細胞の集団を血管の形成を促進する条件に接触させる、前記使用。
- 前記胎盤灌流液細胞の集団が胎盤灌流液由来の全有核細胞である、請求項13に記載の使用。
- 前記細胞の集団を、VEGF(50〜200ng/mL)、TGF−β(1〜5ng/mL)、FGF(10〜50ng/mL)及び1つ又はそれ以上のマトリクスメタロプロテアーゼ(各々1〜3Unit/mL)に接触させる、請求項13に記載の使用。
- 前記胎盤灌流液細胞の集団が、単一の胎盤の灌流から単離される胎盤灌流液細胞を含む、請求項13に記載の使用。
- 前記胎盤灌流液細胞がCD34 + 細胞である、請求項16に記載の使用。
- 前記CD34 + 細胞がCD34 + CD45 − 細胞である、請求項17に記載の使用。
- 前記CD34 + 細胞又はCD34 + CD45 − 細胞が、CD31、CXCR4又はVEGFRの少なくとも1つを、臍帯血由来の同等数のCD34 + 細胞より高いレベルで発現する、請求項16又は17に記載の使用。
- 前記胎盤灌流液細胞の集団が、前記灌流液から単離されない単離CD34 + 細胞を含む、請求項13に記載の使用。
- 前記CD34 + 細胞が胎盤から単離される、請求項20に記載の使用。
- 前記CD34 + 細胞が、臍帯血、胎盤血、末梢血又は骨髄から単離される、請求項20に記載の使用。
- 前記CD34 + 細胞が、CD31、CXCR4又はVEGFRを臍帯血由来の同等数のCD34 + 細胞より高いレベルで発現する、請求項20に記載の使用。
- 前記CD34 + 細胞がCD34 + ,CD45 − 細胞である、請求項20に記載の使用。
- 心臓又は血管疾患、障害、病状若しくは不全を有する患者を処置するための医薬の製造における、ヒト胎盤灌流液又はヒト胎盤灌流液細胞の使用であって、前記ヒト胎盤灌流液又はヒト胎盤灌流液細胞が、前記疾患、障害、病状又は不全を処置するのに十分な量である、前記使用。
- 前記疾患、障害、病状又は不全が、末梢血管疾患、急性若しくは慢性心筋梗塞、心筋症、鬱血性若しくは慢性心不全、心血管虚血、肺高血圧疾患、末梢動脈疾患又はリウマチ性心疾患である、請求項25に記載の使用。
- 前記胎盤灌流液細胞が胎盤灌流液由来の全有核細胞である、請求項25に記載の使用。
- 前記胎盤灌流液細胞の集団が、単一の胎盤の灌流から単離される胎盤灌流液細胞を含む、請求項25に記載の使用。
- 前記胎盤灌流液細胞がCD34+細胞である、請求項28に記載の使用。
- 前記CD34+細胞がCD34+CD45−細胞である、請求項29に記載の使用。
- 前記CD34+細胞又はCD34+CD45−細胞が、CD31、CXCR4又はVEGFRの少なくとも1つを臍帯血由来の同等数のCD34+細胞より高いレベルで発現する、請求項29又は30に記載の使用。
- 前記胎盤灌流液細胞の集団が、前記灌流液から単離されない単離CD34+細胞を含む、請求項25に記載の使用。
- 前記CD34+細胞が胎盤から単離される、請求項32に記載の使用。
- 前記CD34+細胞が、臍帯血、胎盤血、末梢血又は骨髄から単離される、請求項32に記載の使用。
- 前記CD34+細胞が、CD31、CXCR4又はVEGFRを臍帯血由来の同等数のCD34+細胞より高いレベルで発現する、請求項32に記載の使用。
- 前記胎盤灌流液細胞が足場又はマトリクス上にて投与される、請求項25に記載の使用。
- 前記胎盤灌流液細胞が静脈内投与される、請求項25に記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99567907P | 2007-09-26 | 2007-09-26 | |
US60/995,679 | 2007-09-26 | ||
PCT/US2008/011167 WO2009042201A1 (en) | 2007-09-26 | 2008-09-26 | Angiogenic cells from human placental perfusate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014196899A Division JP5985569B2 (ja) | 2007-09-26 | 2014-09-26 | ヒト胎盤灌流液由来の血管形成細胞 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2010540530A JP2010540530A (ja) | 2010-12-24 |
JP2010540530A5 true JP2010540530A5 (ja) | 2011-11-10 |
JP5703493B2 JP5703493B2 (ja) | 2015-04-22 |
Family
ID=40043062
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010526961A Active JP5703493B2 (ja) | 2007-09-26 | 2008-09-26 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2014196899A Active JP5985569B2 (ja) | 2007-09-26 | 2014-09-26 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2016152885A Pending JP2017002071A (ja) | 2007-09-26 | 2016-08-03 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2018129253A Pending JP2018172425A (ja) | 2007-09-26 | 2018-07-06 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2020136719A Pending JP2020189872A (ja) | 2007-09-26 | 2020-08-13 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2022131194A Pending JP2022166249A (ja) | 2007-09-26 | 2022-08-19 | ヒト胎盤灌流液由来の血管形成細胞 |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014196899A Active JP5985569B2 (ja) | 2007-09-26 | 2014-09-26 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2016152885A Pending JP2017002071A (ja) | 2007-09-26 | 2016-08-03 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2018129253A Pending JP2018172425A (ja) | 2007-09-26 | 2018-07-06 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2020136719A Pending JP2020189872A (ja) | 2007-09-26 | 2020-08-13 | ヒト胎盤灌流液由来の血管形成細胞 |
JP2022131194A Pending JP2022166249A (ja) | 2007-09-26 | 2022-08-19 | ヒト胎盤灌流液由来の血管形成細胞 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20090104164A1 (ja) |
EP (1) | EP2205719A1 (ja) |
JP (6) | JP5703493B2 (ja) |
KR (9) | KR20160092062A (ja) |
CN (1) | CN101978045A (ja) |
AU (1) | AU2008305516A1 (ja) |
BR (1) | BRPI0818191A8 (ja) |
CA (1) | CA2700613C (ja) |
IL (4) | IL204762A0 (ja) |
MX (1) | MX2010003217A (ja) |
RU (1) | RU2010116271A (ja) |
WO (1) | WO2009042201A1 (ja) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
EP2206772A3 (en) | 2000-12-06 | 2010-08-04 | Robert J. Hariri | Method of collecting placental stem cells |
MX348185B (es) * | 2001-02-14 | 2017-06-02 | Anthrogenesis Corp | Placenta de mamíferos postparto, su uso y células madres placentales extraídas de ella. |
US7700090B2 (en) * | 2002-02-13 | 2010-04-20 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
US20040171147A1 (en) * | 2002-11-26 | 2004-09-02 | Hariri Robert J. | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
GB0321337D0 (en) * | 2003-09-11 | 2003-10-15 | Massone Mobile Advertising Sys | Method and system for distributing advertisements |
EP1738253A4 (en) * | 2004-03-26 | 2009-07-22 | Celgene Corp | SYSTEMS AND METHOD FOR PROVIDING A STEM CELL BENCH |
JP5203212B2 (ja) * | 2005-10-13 | 2013-06-05 | アントフロゲネシス コーポレーション | 胎盤由来幹細胞からのオリゴデンドロサイトの産生 |
RS53210B (en) | 2005-10-13 | 2014-08-29 | Anthrogenesis Corporation | IMMUNOMODULATION USING PLACENTA CELL CELLS |
AU2006332680A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Improved composition for collecting and preserving placental stem cells and methods of using the composition |
WO2007079183A2 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Placental stem cell populations |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
EP2084268B1 (en) | 2006-10-23 | 2018-09-26 | Celularity, Inc. | Methods and compositions for treatment of bone defects with placental cell populations |
AU2008216748A1 (en) * | 2007-02-12 | 2008-08-21 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45- placental stem cell-enriched cell populations |
RS52921B (en) | 2007-02-12 | 2014-02-28 | Anthrogenesis Corporation | TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
KR20160092062A (ko) * | 2007-09-26 | 2016-08-03 | 안트로제네시스 코포레이션 | 인간 태반 관류액으로부터의 혈관형성 세포 |
PL2203176T3 (pl) | 2007-09-28 | 2015-05-29 | Anthrogenesis Corp | Hamowanie nowotworu za pomocą perfuzatu łożyska ludzkiego i ludzkich łożyskowych pośrednich komórek NK |
KR20200143506A (ko) * | 2008-08-20 | 2020-12-23 | 안트로제네시스 코포레이션 | 단리된 태반 세포를 사용한 뇌졸중 치료 |
US10104880B2 (en) | 2008-08-20 | 2018-10-23 | Celularity, Inc. | Cell composition and methods of making the same |
CA2965883C (en) | 2008-08-22 | 2020-05-12 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
US8367409B2 (en) | 2008-11-19 | 2013-02-05 | Anthrogenesis Corporation | Amnion derived adherent cells |
US8586360B2 (en) | 2009-07-02 | 2013-11-19 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
US9163212B2 (en) * | 2010-01-25 | 2015-10-20 | Warsaw Orthopedic, Inc. | Osteogenic cell delivery matrix |
ES2646750T3 (es) | 2010-01-26 | 2017-12-15 | Anthrogenesis Corporation | Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias |
AR080222A1 (es) | 2010-02-18 | 2012-03-21 | Osiris Therapeutics Inc | Productos terapeuticos que comprenden dispersiones placentarias vitalizadas |
EP3088512B1 (en) | 2010-04-07 | 2019-12-11 | Celularity, Inc. | Use of placental stem cells for treating heart and circulatory diseases by promoting angiogenesis |
MX2012011543A (es) | 2010-04-08 | 2013-05-06 | Anthrogenesis Corp | Tratamiento de sarcoidosis empleando celulas madre placentarias. |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
EP2593542B1 (en) | 2010-07-13 | 2018-01-03 | Anthrogenesis Corporation | Methods of generating natural killer cells |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
CN113559126A (zh) | 2011-06-01 | 2021-10-29 | 人类起源公司 | 利用胎盘干细胞治疗疼痛 |
US9925221B2 (en) | 2011-09-09 | 2018-03-27 | Celularity, Inc. | Treatment of amyotrophic lateral sclerosis using placental stem cells |
AU2013204922B2 (en) | 2012-12-20 | 2015-05-14 | Celgene Corporation | Chimeric antigen receptors |
WO2014123879A1 (en) | 2013-02-05 | 2014-08-14 | Anthrogenesis Corporation | Natural killer cells from placenta |
EP2970914B1 (en) | 2013-03-13 | 2019-07-03 | The University of Queensland | A method of isolating cells for therapy and prophylaxis |
CN111643663A (zh) | 2013-03-15 | 2020-09-11 | 细胞基因公司 | 修饰的t淋巴细胞 |
KR20150139569A (ko) | 2013-04-02 | 2015-12-11 | 유니버시티 오브 플로리다 리서치 파운데이션, 인크. | 혈관형성의 유도 및 조절을 위한 조성물 및 방법 및 혈관형성 조절 인자를 확인하기 위한 방법 및 분석법 |
KR20240023709A (ko) | 2013-11-15 | 2024-02-22 | 안트로제네시스 코포레이션 | 사람 태반 관류액 세포를 포함하는 조성물, 상기 세포의 부분모집단 및 이의 용도 |
CN103756965B (zh) * | 2014-01-27 | 2016-04-06 | 山东省齐鲁干细胞工程有限公司 | 一种从胎盘中灌洗造血干细胞的方法 |
CN104152405B (zh) * | 2014-08-15 | 2016-06-29 | 博雅干细胞科技有限公司 | 从胎盘中分离提取造血干细胞的方法 |
US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
WO2017014561A1 (ko) * | 2015-07-20 | 2017-01-26 | 가톨릭대학교 산학협력단 | 제대혈 cd34 양성 세포에서 골수유래억제세포로의 분화 유도 및 증식 방법, 및 상기 골수유래억제세포의 용도 |
US11690877B2 (en) * | 2015-08-12 | 2023-07-04 | Cha Biotech Co., Ltd. | Umbilical cord-derived adherent stem cells, preparation method therefor, and use thereof |
CA3046078A1 (en) * | 2016-12-05 | 2018-06-14 | Celularity Inc. | Treatment of lymphedema and related conditions using placental adherent cells |
CN107058224B (zh) * | 2017-02-10 | 2020-08-21 | 广东唯泰生物科技有限公司 | 一种以胎盘为来源的造血干细胞提取及冻存方法 |
SG11202105213XA (en) | 2018-11-30 | 2021-06-29 | Celularity Inc | Expansion of natural killer cells and ilc3 cells with novel aromatic compounds |
CN109652372A (zh) * | 2019-01-09 | 2019-04-19 | 陕西九州细胞基因工程有限公司 | 一种人胎盘组织源造血干细胞的快速分离、制备方法 |
JP6977969B2 (ja) * | 2019-03-22 | 2021-12-08 | 株式会社ガイアバイオメディシン | 免疫細胞提供システム |
WO2020252464A1 (en) | 2019-06-14 | 2020-12-17 | Celularity Inc. | Populations of natural killer cells for treating cancers |
WO2021016621A1 (en) | 2019-07-25 | 2021-01-28 | Celularity Inc. | Populations of natural killer cells comprising a cd38 chimeric antigen receptor |
WO2021022229A1 (en) | 2019-07-31 | 2021-02-04 | Celularity Inc. | Populations of natural killer cells comprising a cleavage resistant cd16 |
WO2021113849A1 (en) | 2019-12-05 | 2021-06-10 | Celularity Inc. | Her2+ cancer treatment with populations of natural killer cells comprising a cleavage resistant cd16 |
US20220000919A1 (en) | 2020-01-29 | 2022-01-06 | Celularity Inc. | Placental derived natural killer cells for treatment of coronavirus infections |
WO2023278628A1 (en) | 2021-06-29 | 2023-01-05 | Celularity Inc. | Human placental hematopoietic stem cell derived natural killer cells in acute myeloid leukemia (aml) remission with minimal residual disease (mrd) or relapsed/refractory aml |
WO2023010123A1 (en) | 2021-07-29 | 2023-02-02 | Celularity Inc. | Placenta-dervied nk cells as a senolytic for therapeutic and other uses |
WO2023137344A1 (en) | 2022-01-11 | 2023-07-20 | Celularity Inc. | Cleavage resistant cd16 constructs and uses thereof |
Family Cites Families (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862002A (en) * | 1962-05-08 | 1975-01-21 | Sanfar Lab Inc | Production of physiologically active placental substances |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5004681B1 (en) * | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
US5192553A (en) * | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
CN1089344C (zh) * | 1993-03-31 | 2002-08-21 | 普罗神经细胞有限公司 | 干细胞增生的抑制剂及其应用 |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US6288030B1 (en) * | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
PT952792E (pt) * | 1994-06-06 | 2003-12-31 | Osiris Therapeutics Inc | Biomatriz para regeneracao dos tecidos |
US6174333B1 (en) * | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
US6103522A (en) * | 1994-07-20 | 2000-08-15 | Fred Hutchinson Cancer Research Center | Human marrow stromal cell lines which sustain hematopoiesis |
US5874301A (en) * | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
US5716616A (en) * | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
US5733541A (en) * | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
US5925567A (en) * | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
US5877299A (en) * | 1995-06-16 | 1999-03-02 | Stemcell Technologies Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
ATE319827T1 (de) * | 1995-11-17 | 2006-03-15 | Asahi Chemical Ind | Polypeptid, das die differenzierung unterdrueckt |
US5716794A (en) * | 1996-03-29 | 1998-02-10 | Xybernaut Corporation | Celiac antigen |
ATE439849T1 (de) * | 1996-04-19 | 2009-09-15 | Osiris Therapeutics Inc | Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen |
US5919176A (en) * | 1996-05-14 | 1999-07-06 | Children's Hospital Medical Center Of Northern California | Apparatus and method for collecting blood from an umbilical cord |
US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US5916202A (en) * | 1996-08-30 | 1999-06-29 | Haswell; John N. | Umbilical cord blood collection |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
US5879318A (en) * | 1997-08-18 | 1999-03-09 | Npbi International B.V. | Method of and closed system for collecting and processing umbilical cord blood |
AU9127098A (en) * | 1997-09-04 | 1999-03-22 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
AU749675B2 (en) * | 1998-03-13 | 2002-07-04 | Mesoblast International Sarl | Uses for human non-autologous mesenchymal stem cells |
JP4526186B2 (ja) * | 1998-06-08 | 2010-08-18 | オシリス セラピューティクス,インコーポレイテッド | 造血幹細胞を試験管内で維持する方法と組成物 |
US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
JP3089299B2 (ja) * | 1998-12-14 | 2000-09-18 | 京都大学長 | 生体内に毛細血管が豊富な組織を作成するのに用いる新生血管床形成用用具 |
JP4523169B2 (ja) * | 1999-02-04 | 2010-08-11 | プルリステム リミテッド | 造血幹細胞および/または前駆細胞を維持および増加するための方法および装置 |
FR2792202B1 (fr) * | 1999-04-19 | 2003-06-13 | Pharmascience Lab | Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US20050009876A1 (en) * | 2000-07-31 | 2005-01-13 | Bhagwat Shripad S. | Indazole compounds, compositions thereof and methods of treatment therewith |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
EP2206772A3 (en) * | 2000-12-06 | 2010-08-04 | Robert J. Hariri | Method of collecting placental stem cells |
US20030045552A1 (en) * | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
MX348185B (es) * | 2001-02-14 | 2017-06-02 | Anthrogenesis Corp | Placenta de mamíferos postparto, su uso y células madres placentales extraídas de ella. |
EP2316918B1 (en) * | 2001-02-14 | 2015-07-01 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
CA2396536A1 (en) * | 2001-08-10 | 2003-02-10 | Saiko Uchida | Human stem cells originated from human amniotic mesenchymal cell layer |
AU2003205266A1 (en) * | 2002-01-22 | 2003-09-02 | Advanced Cell Technology, Inc. | Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
WO2003068937A2 (en) * | 2002-02-13 | 2003-08-21 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
GB0205867D0 (en) * | 2002-03-13 | 2002-04-24 | Univ Nottingham | Polymer composite loaded with functioning matter |
US20030187515A1 (en) * | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
EP1525308A4 (en) * | 2002-05-30 | 2006-11-02 | Celgene Corp | METHODS OF USING JNK OR MKK INHIBITORS TO MODULATE CELL DIFFERENTIATION AND TREAT MYELOPROLIFERATIVE DISORDERS AND MYELODYSPLASIC SYNDROMES |
US7422736B2 (en) * | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
JP4480128B2 (ja) * | 2002-11-20 | 2010-06-16 | 独立行政法人科学技術振興機構 | マトリックスメタロプロテアーゼ−9の産生を阻害するための薬剤 |
NZ542127A (en) * | 2003-02-13 | 2008-04-30 | Anthrogenesis Corp | Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
CA2530255C (en) * | 2003-06-27 | 2015-12-08 | Ethicon, Incorporated | Soft tissue repair and regeneration using postpartum-derived cells |
US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
AR046123A1 (es) * | 2003-10-17 | 2005-11-23 | Crc For Innovative Dairy Produ | Aislamiento de celulas simil-celulas madre, uso de las mismas |
AU2004309090A1 (en) * | 2003-12-29 | 2005-07-14 | Aventis Pharma Sa | Treatment of coronary or peripheral ischemia |
RU2006144851A (ru) * | 2004-06-15 | 2008-06-20 | Бакстер Интернэшнл Инк. (Us) | Применение терапевтических средств ex-vivo в виде твердых микрочастиц |
US7147626B2 (en) * | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
US7909806B2 (en) * | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
US8017395B2 (en) * | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
WO2006074308A2 (en) * | 2005-01-07 | 2006-07-13 | Wake Forest University Health Sciences | Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
WO2006091766A2 (en) * | 2005-02-24 | 2006-08-31 | Jau-Nan Lee | Human trophoblast stem cells and use thereof |
US20060222634A1 (en) * | 2005-03-31 | 2006-10-05 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
WO2006108229A1 (en) * | 2005-04-12 | 2006-10-19 | Angioblast Systems, Inc. | Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
NZ564563A (en) * | 2005-06-10 | 2011-03-31 | Celgene Corp | Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions |
KR20080026198A (ko) * | 2005-06-30 | 2008-03-24 | 안트로제네시스 코포레이션 | 태반 유도된 콜라겐 바이오패브릭을 사용한 고막의 복원 |
EP1919365A2 (en) * | 2005-07-13 | 2008-05-14 | Anthrogenesis Corporation | Ocular plug formed from placenta derived collagen biofabric |
EP1919500A2 (en) * | 2005-07-13 | 2008-05-14 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
WO2007011693A2 (en) * | 2005-07-14 | 2007-01-25 | Medistem Laboratories, Inc. | Compositions of placentally-derived stem cells for the treatment of cancer |
RS53210B (en) * | 2005-10-13 | 2014-08-29 | Anthrogenesis Corporation | IMMUNOMODULATION USING PLACENTA CELL CELLS |
EP1979050B1 (en) * | 2005-12-28 | 2017-04-19 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using postpartum-derived cells |
WO2007079183A2 (en) * | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Placental stem cell populations |
WO2007146105A2 (en) * | 2006-06-05 | 2007-12-21 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
US20080050814A1 (en) * | 2006-06-05 | 2008-02-28 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
KR20090031895A (ko) * | 2006-06-09 | 2009-03-30 | 안트로제네시스 코포레이션 | 태반 니치 및 줄기 세포 배양을 위한 이의 용도 |
US20090081171A1 (en) * | 2006-08-11 | 2009-03-26 | Yu-Show Fu | Cell system for alleviating syndromes of Parkinson's disease in a mammal |
WO2008021391A1 (en) * | 2006-08-15 | 2008-02-21 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
US20080050347A1 (en) * | 2006-08-23 | 2008-02-28 | Ichim Thomas E | Stem cell therapy for cardiac valvular dysfunction |
EP2084268B1 (en) * | 2006-10-23 | 2018-09-26 | Celularity, Inc. | Methods and compositions for treatment of bone defects with placental cell populations |
AU2008216748A1 (en) * | 2007-02-12 | 2008-08-21 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45- placental stem cell-enriched cell populations |
US20090053182A1 (en) * | 2007-05-25 | 2009-02-26 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
US20090016999A1 (en) * | 2007-07-13 | 2009-01-15 | Michael Cohen | Embryonic cell compositions for wound treatment |
AU2008201946B2 (en) * | 2007-09-13 | 2014-07-03 | Librach, Clifford L | Method of Isolation and Use of Cells Derived From First Trimester Umbilical Cord Tissue |
BRPI0815946B8 (pt) * | 2007-09-19 | 2021-05-25 | Pluristem Ltd | artigo de fabricação |
KR20160092062A (ko) * | 2007-09-26 | 2016-08-03 | 안트로제네시스 코포레이션 | 인간 태반 관류액으로부터의 혈관형성 세포 |
US10104880B2 (en) * | 2008-08-20 | 2018-10-23 | Celularity, Inc. | Cell composition and methods of making the same |
KR20200143506A (ko) * | 2008-08-20 | 2020-12-23 | 안트로제네시스 코포레이션 | 단리된 태반 세포를 사용한 뇌졸중 치료 |
CA2965883C (en) * | 2008-08-22 | 2020-05-12 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
CN201299504Y (zh) * | 2008-11-11 | 2009-09-02 | 薛华 | 一种方便搭挂的毛巾 |
US8586360B2 (en) * | 2009-07-02 | 2013-11-19 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
TWI395125B (zh) * | 2009-07-14 | 2013-05-01 | Sonix Technology Co Ltd | 電容式觸控感應電路 |
-
2008
- 2008-09-26 KR KR1020167020487A patent/KR20160092062A/ko active Application Filing
- 2008-09-26 CN CN2008801178057A patent/CN101978045A/zh active Pending
- 2008-09-26 KR KR1020197012717A patent/KR20190050867A/ko not_active Application Discontinuation
- 2008-09-26 KR KR1020217028887A patent/KR20210118946A/ko not_active Application Discontinuation
- 2008-09-26 EP EP08833350A patent/EP2205719A1/en not_active Withdrawn
- 2008-09-26 KR KR1020207033934A patent/KR20200136051A/ko not_active Application Discontinuation
- 2008-09-26 BR BRPI0818191A patent/BRPI0818191A8/pt not_active Application Discontinuation
- 2008-09-26 CA CA2700613A patent/CA2700613C/en active Active
- 2008-09-26 KR KR1020157020016A patent/KR101645311B1/ko active IP Right Grant
- 2008-09-26 KR KR1020107008970A patent/KR101644659B1/ko active IP Right Grant
- 2008-09-26 AU AU2008305516A patent/AU2008305516A1/en not_active Abandoned
- 2008-09-26 KR KR1020187015067A patent/KR20180059583A/ko not_active Application Discontinuation
- 2008-09-26 KR KR1020227028466A patent/KR20220122774A/ko not_active Application Discontinuation
- 2008-09-26 JP JP2010526961A patent/JP5703493B2/ja active Active
- 2008-09-26 RU RU2010116271/10A patent/RU2010116271A/ru not_active Application Discontinuation
- 2008-09-26 WO PCT/US2008/011167 patent/WO2009042201A1/en active Application Filing
- 2008-09-26 KR KR1020207011050A patent/KR20200043517A/ko not_active Application Discontinuation
- 2008-09-26 US US12/239,679 patent/US20090104164A1/en not_active Abandoned
- 2008-09-26 MX MX2010003217A patent/MX2010003217A/es not_active Application Discontinuation
-
2010
- 2010-03-25 IL IL204762A patent/IL204762A0/en active IP Right Grant
-
2014
- 2014-09-26 JP JP2014196899A patent/JP5985569B2/ja active Active
-
2015
- 2015-11-17 IL IL242645A patent/IL242645B/en active IP Right Grant
- 2015-11-17 IL IL242644A patent/IL242644B/en active IP Right Grant
-
2016
- 2016-08-03 JP JP2016152885A patent/JP2017002071A/ja active Pending
-
2018
- 2018-06-26 IL IL260292A patent/IL260292A/en unknown
- 2018-07-06 JP JP2018129253A patent/JP2018172425A/ja active Pending
-
2020
- 2020-08-13 JP JP2020136719A patent/JP2020189872A/ja active Pending
-
2022
- 2022-08-19 JP JP2022131194A patent/JP2022166249A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010540530A5 (ja) | ||
RU2010116271A (ru) | Ангиогенные клетки из плацентарного перфузата человека | |
Basir et al. | Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock | |
Strauer et al. | Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | |
Losordo et al. | Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies | |
Tuma et al. | Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina | |
Shiraishi et al. | Human heterotaxy syndrome–from molecular genetics to clinical features, management, and prognosis– | |
Accornero et al. | Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism | |
Ohuchi et al. | Hemodynamic determinants of mortality after Fontan operation | |
Strauer et al. | Stem cell therapy in perspective | |
dealmeida et al. | Increased ventricular preload is compensated by myocyte proliferation in normal and hypoplastic fetal chick left ventricle | |
Yamada et al. | Embryonic stem cell therapy of heart failure in genetic cardiomyopathy | |
Licker et al. | Cardioprotective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery | |
Tran et al. | Pathophysiology of exercise intolerance in pulmonary arterial hypertension | |
WO2006121532A3 (en) | Treatment for heart disease | |
Chachques | Cellular cardiac regenerative therapy in which patients? | |
Rog et al. | Clinical evaluation of exercise capacity in adults with systemic right ventricle | |
Zhou et al. | A combined ultrafiltration strategy during pediatric cardiac surgery: a prospective, randomized, controlled study with clinical outcomes | |
Zhong et al. | The current status and future of cardiac stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy | |
Wright et al. | High systemic vascular resistance and sudden cardiovascular collapse in recovering Norwood patients | |
Figuinha et al. | Heyde's syndrome: case report and literature review | |
Gorla et al. | Unrepaired Tetralogy of Fallot in an 85‐Year‐Old Man | |
Yamada et al. | Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype | |
Cedars et al. | Heart failure in adults who had the Fontan procedure: natural history, evaluation, and management | |
Nath et al. | Can the Kawashima procedure be performed in younger patients? |